An intra-axial wolf in extra-axial clothing: A rare case of high-grade astrocytoma and literature review Authors: Talha Sajid, Muhammad Arslan Iqbal, Khawar Zaman, Salman Ahmed, Umer Farooq Raina Published: 2026 ABSTRACT Background: High-grade astrocytomas are typically intra-axial, diffusely infiltrating brain tumors. Their presentation as a primary dural-based, extra-axial mass mimicking an aggressive meningioma is exceptionally rare, creating a significant diagnostic challenge and potential for preoperative misdiagnosis.Case Description: A 40-year-old male presented with a 2.5-year history of headache and vertigo, followed by generalized seizures. Neurological examination revealed bilateral papilledema with subtle right-sided upper motor neuron signs. Imaging revealed a large, heterogeneously enhancing, left fronto-temporo-parietal mass with broad dural attachment, calvarial erosion, and mass effect, but notably minimal perilesional edema. The primary radiological differential diagnoses included atypical meningioma, dural-based lymphoma, and metastasis. Following maximal safe resection, histopathological and molecular analysis confirmed the diagnosis of an astrocytoma, isocitrate dehydrogenase (IDH)-mutant, central nervous system World Health Organization grade 4. The patient received adjuvant focal radiotherapy (59.4 Gy in 33 fractions) and at 6-month follow-up was neurologically stable, seizure-free, and demonstrated marked radiological regression.Conclusion: This case highlights that high-grade astrocytoma, including IDH-mutant variants, can present with classic extra-axial and meningioma-like imaging features. It underscores the critical importance of definitive histomolecular diagnosis over radiographic impression alone to guide appropriate, biology-directed management. The patient demonstrated an encouraging early clinical and radiological response following surgical resection and radiotherapy. INTRODUCTION High-grade gliomas are the most common primary malignant tumors of the adult central nervous system and, according to the 2021 World Health Organization (WHO) classification, are defined as diffusely infiltrating intra-axial neoplasms of the cerebral hemispheres.[1,7] Typically, glioblastomas and other high-grade astrocytic tumors arise within the brain parenchyma and present as ring-enhancing intra-axial masses with surrounding edema and mass effect.[3,6,9] Rarely,high-grade gliomas may originate from, or predominantly involve, the dura, mimicking an extra-axial lesion.[3,5,11] Case reports from both international and regional centers have documented dural-based glioblastomas or high-grade astrocytomas that simulate meningiomas due to broad dural attachment, a “dural tail” sign, or even bone invasion.[3,9,11,12] Other studies have reported transdural or epidural tumor extension with skull-base infiltration, calvarial destruction, or subcutaneous mass formation, further complicating the radiological diagnosis.[5,13,15] In specialized anatomical regions such as the cerebellopontine angle and internal auditory canal, dural-based glioblastomas remain an exceptional diagnostic challenge.[8,16] Radiologic reviews also emphasize that malignant gliomas are part of a spectrum of dural-based lesions that may mimic meningiomas, including solitary fibrous tumors, hemangiopericytomas, and metastatic disease.[2] Despite these reports, the literature largely focuses on isocitrate dehydrogenase (IDH)-wildtype glioblastomas in older adults, with limited molecular characterization or follow-up.[3,9] There are few reports on high-grade or IDH-mutant astrocytomas presenting primarily as dural-based lesions, particularly de novo without prior intra-axial origin or recurrence.[10] Our rationale for presenting this case is to expand understanding of this rare presentation, illustrate its radiological and histopathological features, and highlight the importance of comprehensive molecular profiling to guide management. In addition, this report compares our findings with previously published cases of dural-mimicking high-grade gliomas to highlight key diagnostic challenges and clinical implications. CASE PRESENTATION A 40-year-old right-handed male, previously healthy and with no history of smoking or alcohol use, presented with chronic headache and vertigo for approximately 2.5 years. The headache was intermittent, diffuse, and gradually progressive. Vertigo was described as episodic dizziness with a sense of imbalance. For the past 6 months before presentation, he developed seizures that were generalized tonic–clonic in nature, with increasing frequency. There were no other associated complaints. There was a remote history of tuberculosis in childhood, reportedly treated completely. On examination, the patient was conscious, alert, and oriented, with intact higher mental functions. Fundoscopic examination revealed bilateral papilledema. Motor examination showed full strength in all four limbs; however, plantar response was upgoing on the right side, and a positive pronator drift was noted in the right upper limb. The remainder of the systemic examination was unremarkable. Based on the patient’s history of progressive headache, seizures, and signs of raised intracranial pressure with contralateral upper motor neuron findings, the initial differential diagnoses included intracranial space-occupying lesions such as glioma, meningioma, metastatic tumor, primary central nervous system lymphoma, and solitary fibrous tumor. Given the patient’s remote history of tuberculosis, intracranial tuberculoma was also considered. On non-contrast computed tomography, a linear calcific focus measuring approximately 32 × 3 mm was noted along the medial aspect of the lesion. Thinning and focal erosion of the overlying calvarium [Figure 1], predominantly involving the left temporal bone, were identified. Hypodense edematous changes were present in the anteroinferior aspect of the left frontal lobe. Pre-operative imaging. (A and B) Axial images of non-contrast CT brain showing left sided extraaxial hypodense mass (Green asterix) compressing the cortex with thin streak of calcification on the medial aspect of the lesion (Green arrow). (C and D) T2 axial images of MRI brain showing hyperintensity in left fronto-temporoparietal region (Green asterisk). (E and F) Post contrast axial images of MRI brain showing heterogenous enhancement (Green asterisk). CT: Computed tomography, MRI: Magnetic resonance imaging. Magnetic resonance imaging (MRI) revealed a large extra-axial-appearing infiltrative mass in the left temporo-parietal region with extension into the left frontal convexity. The lesion was hypointense on T1, hyperintense on T2, and heterogeneously hyperintense on fluid-attenuated inversion recovery with internal hypointense areas. Post-contrast images showed mild heterogeneous enhancement. The lesion measured approximately 47 × 110 × 83 mm (transverse × anteroposterior × craniocaudal). Limited diffusion-weighted imaging demonstrated partial and questionable restriction. Minimal perilesional edema was observed despite the large size. There was marked compression of adjacent cerebral structures, including basal ganglia, midbrain, and lateral ventricles, with a rightward midline shift of ~9 mm. Mild cortical thinning and flattening of the posterior globes were also noted. Radiological differential diagnoses included atypical meningioma, dural-based lymphoma, and metastasis. Preoperative radiology is given in Figure 1. The patient underwent a left frontotemporoparietal craniotomy with the aim of maximal safe resection. Intraoperatively, the lesion appeared predominantly extra-axial with broad dural contact and significant compression of the underlying cerebral cortex, as shown in Figure 2A-C. The tumor had a soft to moderately firm consistency and was moderately vascular in nature. Although the lesion appeared largely extra-axial, focal areas of adherence to the cortical surface were noted. Near-total resection of the tumor was achieved. The overlying calvarial bone was thinned but did not show gross tumor infiltration; therefore, the bone flap was preserved and replaced at the end of the procedure. Per-operative and histopathology imaging. (A-C) Intra-operative images of extra-axial mass (Green arrows in B and C), it was soft in consistency and easily suck able. 2 D Magnification is 200x. (D) Hematoxylin and eosin staining shows microvascular proliferation with oval to elongated nuclei. (E) P53 staining shows aberrant overexpression. (F) Isocitrate dehydrogenase positive and (G) positive OLIG2. Histopathology revealed an infiltrating astrocytic neoplasm with increased cellularity, nuclear atypia, and microvascular proliferation. Immunohistochemistry showed positivity for IDH and Oligodendrocyte Transcription Factor 2 (OLIG2), loss of Alpha Thalassemia/Mental Retardation Syndrome X-linked (ATRX) expression, aberrant p53 overexpression, and Ki-67 labeling index of ~7–8%, consistent with astrocytoma, IDH-mutant, central nervous system (CNS) WHO grade 4.[1,7]Histopathology is represented in Figure 2D-G. Postoperative MRI demonstrated residual abnormal signal intensity with peripheral enhancement measuring 21 × 78 × 54 mm. The patient received focal radiotherapy to a total dose of 59.4 Gy in 33 fractions. Chemotherapy with temozolomide was not administered due to the absence of O6-methylguanineDNA methyltransferase (MGMT) promoter methylation testing and local resource limitations. Six-month follow-up MRI showed marked regression with a small residual lesion measuring 12 × 9 × 11 mm, no vasogenic edema, and stable midline structures [Figure 3]. The patient remained seizure-free and neurologically stable. Written informed consent was obtained from the patient’s guardian for publication of this case report and any accompanying images. Post-operative imaging. (A and B) Post-operative axial images of non-contrast CT brain showing excision of tumor (Green asterisk) and streak of calcification can be appreciated as well (Green arrow). (C and D) Post-operative and pre-radiation post-contrast MRI brain showing axial images with residual enhancement of lesion with significant reduction in size (Green asterisk). (E and F) Post-radiation postcontrast MRI brain showing axial images with almost resolution of the lesion (Green arrows). CT: Computed tomography, MRI: Magnetic resonance imaging. DISCUSSION High-grade astrocytomas that mimic extra-axial tumors are extremely rare. Demographically, most dural-based glioblastomas occur in older adults, although cases have been reported across a wide age spectrum ranging from pediatric to elderly populations.[5,6,14] Our patient, aged 40 years, falls within the mid-adult age group reported in several previous cases. Symptomatology is often nonspecific and may include headache, seizures, focal neurological deficits, or visual disturbances, frequently resembling the presentation of meningiomas or other dural-based tumors.[8,15,16] In our patient, a prolonged symptomatic history of approximately 2.5 years was observed before definitive diagnosis. Similar prolonged clinical courses have been reported in other dural-mimicking gliomas, possibly due to the predominantly extra-axial growth pattern producing gradual mass effect rather than rapid parenchymal infiltration.[5,15] Radiologically, dural-based high-grade astrocytomas may demonstrate broad dural attachment, dural tail-like enhancement, calvarial erosion, heterogeneous contrast enhancement, and relatively limited peritumoral edema.[4,9,11,12] These imaging characteristics closely resemble aggressive meningiomas and frequently lead to preoperative misdiagnosis.[3,9,11,12] Advanced imaging modalities such as magnetic resonance spectroscopy may provide additional clues by demonstrating metabolic patterns more consistent with high-grade glioma rather than meningioma.[9] Surgical management of such lesions should prioritize maximal safe resection. In the present case, near-total resection was achieved through a frontotemporoparietal craniotomy. Intraoperatively the tumor appeared predominantly extra-axial with compression of the adjacent cortex. The calvarial bone flap was thinned but did not demonstrate gross tumor infiltration and was therefore preserved and replaced. Histopathological confirmation remains essential because intraoperative appearance alone may not reliably distinguish gliomas from meningiomas or other dural-based tumors.[3,5,15] Histopathological examination in the present case demonstrated an infiltrating astrocytic neoplasm with increased cellularity, nuclear atypia, and microvascular proliferation. Immunohistochemistry revealed positivity for IDH and OLIG2, loss of ATRX expression, and p53 overexpression, consistent with astrocytoma, IDH-mutant, CNS WHO grade 4 according to the 2021 WHO classification.[1,7] Molecular profiling has become increasingly important in distinguishing tumor subtypes and predicting prognosis. Despite the predominantly extra-axial appearance on imaging and intraoperatively, the possibility of an intra-axial glioma with secondary dural extension cannot be completely excluded. Similar diagnostic ambiguity has been described in previously reported cases where glioblastomas demonstrated broad dural attachment or dural tail-like enhancement, closely mimicking meningiomas.[3,9,11] A review of previously reported cases of high-grade gliomas presenting as dural-based or extra-axial lesions is summarized in Table 1. Most reported cases involved glioblastoma occurring in older adults and frequently lacked detailed molecular characterization. In contrast, the present case represents a molecularly characterized astrocytoma, IDH-mutant, CNS WHO grade 4, which is rarely described with predominantly extra-axial imaging features. The introduction of integrated histomolecular classification in the 2021 WHO CNS tumor classification has emphasized the importance of molecular markers such as IDH mutation, ATRX loss, and p53 alterations in defining tumor subtype and prognosis.[1,7] Table 1:Reported cases of high-grade gliomas mimicking dural-based extra-axial lesions in the literature. Reported cases of high-grade gliomas mimicking dural-based extra-axial lesions in the literature. Post-radiotherapy imaging showed marked regression, aligning with the favorable outcomes typically observed in IDH-mutant gliomas.[1,7] Adjuvant therapy, including focal radiotherapy and temozolomide, should follow glioma protocols regardless of the extra-axial appearance of the tumor.[14,15] Standard management of high-grade astrocytomas typically includes maximal safe resection followed by combined chemoradiotherapy. However, chemotherapy with temozolomide was not administered in the present case due to the absence of MGMT promoter methylation testing and local resource limitations. The patient, therefore, received focal radiotherapy after surgery and demonstrated encouraging early clinical and radiological response. Overall, this case emphasizes that aggressive dural-based masses with minimal peritumoral edema should not automatically be presumed to represent meningiomas, and definitive diagnosis requires histopathological and molecular evaluation. Limitations This report has several limitations. First, the follow-up duration of 6 months is relatively short and does not allow definitive conclusions regarding long-term oncologic outcomes. Second, although the lesion demonstrated predominantly extra-axial characteristics radiologically and intraoperatively, a definitive distinction between a primary dural-based tumor and an intra-axial glioma with secondary dural extension cannot be established with certainty. Third, MGMT promoter methylation testing was not available in this case, which limited the use of chemotherapy in the treatment protocol. Clinical recommendations Given the diagnostic challenge posed by dural-based high-grade gliomas, clinicians should maintain a high index of suspicion for glioma when encountering atypical dural-based masses, particularly those with disproportionately minimal perilesional edema. Surgical management should prioritize maximal safe resection, extending to include involved dura and bone where feasible, to improve local control. Crucially, definitive adjuvant therapy must follow molecularly guided glioma protocols, irrespective of an initial radiographic impression suggestive of an extra-axial tumor like a meningioma. Therefore, comprehensive histopathological evaluation supplemented by essential molecular profiling, including IDH status, ATRX, and p53, is strongly recommended for all atypical extra-axial tumors to guide accurate treatment planning and prognostication. CONCLUSION High-grade astrocytomas may rarely present with radiological features suggestive of a dural-based extra-axial lesion, closely mimicking meningioma. This case highlights that atypical dural masses with minimal perilesional edema should prompt consideration of high-grade glioma in the differential diagnosis. In our patient, near-total surgical resection followed by adjuvant radiotherapy resulted in an encouraging early clinical and radiological response. Definitive diagnosis relied on histopathological and molecular evaluation, which ultimately guides appropriate oncologic management.